Linking Innate with Adaptive Immune Response
将先天性与适应性免疫反应联系起来
基本信息
- 批准号:6561442
- 负责人:
- 金额:$ 0.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-01-15 至 2003-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The Innate Immune System provides the first line of defense against pathogens, and plays a critical role in controlling and instructing Adaptive Immunity. This interface was the topic of a highly successful Keystone Symposium that was held in January, 2001 as well as a series of Reviews, News and Views and Research Articles in journals such as Nature, and Science, in the past few years. In addition to having significance to responses to microorganisms, the topic is of major interest to scientists in other areas of immunology including Tumor Immunology, Autoimmunity and Vaccine Development. The meeting will highlight the new frontiers of research on the cells, receptors, signal transduction pathways, and soluble mediators of innate immunity that provide initial host responses and that control adaptive immunity. A multidisciplinary group oftop ranking researchers including molecular biologists, biochemists and cellular immunologists is invited to discuss emerging concepts, novel technologies and new avenues of research. This meeting will be especially rewarding for students and postdoctoral fellows in search of opportunities for future research and challenges.
描述(由申请人提供):先天免疫系统提供了抵抗病原体的第一道防线,并在控制和指导适应性免疫方面发挥关键作用。这个接口是2001年1月举行的一个非常成功的Keystone研讨会的主题,以及过去几年在Nature和Science等期刊上发表的一系列评论,新闻和观点以及研究文章。除了对微生物的反应具有重要意义外,该主题也是免疫学其他领域的科学家的主要兴趣,包括肿瘤免疫学,自身免疫和疫苗开发。会议将突出研究的细胞,受体,信号转导途径,和先天免疫提供初始宿主反应和控制适应性免疫的可溶性介质的新前沿。一个多学科小组的顶级研究人员,包括分子生物学家,生物化学家和细胞免疫学家被邀请讨论新兴概念,新技术和新的研究途径。这次会议将特别有益于学生和博士后研究员在寻找未来的研究和挑战的机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wayne M. Yokoyama其他文献
Immune functions encoded by the natural killer gene complex
自然杀伤基因复合体编码的免疫功能
- DOI:
10.1038/nri1055 - 发表时间:
2003-04-01 - 期刊:
- 影响因子:60.900
- 作者:
Wayne M. Yokoyama;Beatrice F. M. Plougastel - 通讯作者:
Beatrice F. M. Plougastel
The mother-child union: the case of missing-self and protection of the fetus.
母子结合:自我缺失与胎儿保护案例
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:11.1
- 作者:
Wayne M. Yokoyama - 通讯作者:
Wayne M. Yokoyama
Expression of a single inhibitory Ly49 receptor is sufficient to license NK cells for effector functions
单一抑制性 Ly49 受体的表达足以许可 NK 细胞发挥效应功能
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Sytse J. Piersma;Shasha Li;Pamela Wong;Michael D. Bern;Jennifer Poursine‐Laurent;Liping Yang;D. L. Beckman;Bijal A. Parikh;Wayne M. Yokoyama - 通讯作者:
Wayne M. Yokoyama
Structural basis of MHCI antigen presentation sabotage by cowpox CPXV203
- DOI:
10.1016/j.molimm.2012.02.034 - 发表时间:
2012-05-01 - 期刊:
- 影响因子:
- 作者:
William H. McCoy;Xiaoli Wang;Wayne M. Yokoyama;Ted H. Hansen;Daved Fremont - 通讯作者:
Daved Fremont
Catch us if you can
如果你能就抓住我们
- DOI:
10.1038/419679a - 发表时间:
2002-10-17 - 期刊:
- 影响因子:48.500
- 作者:
Wayne M. Yokoyama - 通讯作者:
Wayne M. Yokoyama
Wayne M. Yokoyama的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wayne M. Yokoyama', 18)}}的其他基金
Infectious Disease/Immunology Stimulating Access to Research in Residency (ID/IMM StARR) Program at Washington University
华盛顿大学传染病/免疫学促进住院医师研究 (ID/IMM StARR) 项目
- 批准号:
10592699 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
ORIGINS AND FUNCTIONS OF UTERINE NATURAL KILLER CELLS IN PREGNANCY
妊娠期子宫自然杀伤细胞的起源和功能
- 批准号:
10451584 - 财政年份:2018
- 资助金额:
$ 0.8万 - 项目类别:
ORIGINS AND FUNCTIONS OF UTERINE NATURAL KILLER CELLS IN PREGNANCY
妊娠期子宫自然杀伤细胞的起源和功能
- 批准号:
10216997 - 财政年份:2018
- 资助金额:
$ 0.8万 - 项目类别:
ORIGINS AND FUNCTIONS OF UTERINE NATURAL KILLER CELLS IN PREGNANCY
妊娠期子宫自然杀伤细胞的起源和功能
- 批准号:
9980287 - 财政年份:2018
- 资助金额:
$ 0.8万 - 项目类别:
ORIGINS AND FUNCTIONS OF UTERINE NATURAL KILLER CELLS IN PREGNANCY
妊娠期子宫自然杀伤细胞的起源和功能
- 批准号:
9762839 - 财政年份:2018
- 资助金额:
$ 0.8万 - 项目类别:
相似海外基金
UBR5's mechanisms of action in tumorigenesis and immunoregulation
UBR5在肿瘤发生和免疫调节中的作用机制
- 批准号:
10659844 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
Unprecedented and potent immunoregulation provided by protein capture with functionalized small synthetic nucleic acids
通过功能化小合成核酸捕获蛋白质提供前所未有的有效免疫调节
- 批准号:
23H00317 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
IL-27-mediated immunoregulation in HSV-1-induced stromal keratitis
HSV-1 诱导的基质性角膜炎中 IL-27 介导的免疫调节
- 批准号:
10737119 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
Elucidation of the mechanisms relating to immunoregulation in oral tumor microenvironment and development of novel treatments
阐明口腔肿瘤微环境中免疫调节相关机制并开发新疗法
- 批准号:
23H03104 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Environmental arsenic, immunoregulation, and viral disease risk
环境砷、免疫调节和病毒性疾病风险
- 批准号:
10589936 - 财政年份:2022
- 资助金额:
$ 0.8万 - 项目类别:
Immunoregulation of cellular immunity and tissue homeostasis during Chagas' disease
恰加斯病期间细胞免疫和组织稳态的免疫调节
- 批准号:
10448950 - 财政年份:2022
- 资助金额:
$ 0.8万 - 项目类别:
Discovering modulators of exonucleases PLD3 and PLD4 for immunoregulation
发现用于免疫调节的核酸外切酶 PLD3 和 PLD4 调节剂
- 批准号:
10620110 - 财政年份:2022
- 资助金额:
$ 0.8万 - 项目类别:
Environmental arsenic, immunoregulation, and viral disease risk
环境砷、免疫调节和病毒性疾病风险
- 批准号:
10452270 - 财政年份:2022
- 资助金额:
$ 0.8万 - 项目类别:
Discovering modulators of exonucleases PLD3 and PLD4 for immunoregulation
发现用于免疫调节的核酸外切酶 PLD3 和 PLD4 调节剂
- 批准号:
10353980 - 财政年份:2022
- 资助金额:
$ 0.8万 - 项目类别:
Immunoregulation of cellular immunity and tissue homeostasis during Chagas' disease
恰加斯病期间细胞免疫和组织稳态的免疫调节
- 批准号:
10600054 - 财政年份:2022
- 资助金额:
$ 0.8万 - 项目类别:














{{item.name}}会员




